Cannabis
PURA Announces First New CBD-Infused Product with Alkame Holdings
Dallas, Texas–(Newsfile Corp. – May 11, 2021) – Puration, Inc. (OTC Pink: PURA) and Alkame Holdings Inc. (OTC Pink: ALKM) today announced finalizing a formula for a new CBD-infused liquid sugar and plans to soon begin production.
In December 2020, PURA and ALKM announced plans to produce and test market a CBD-infused liquid sugar, a CBD-infused pet food supplement and a CBD sexual wellness flavored lubricant.
ALKM currently bottles PURA’s EVERx CBD Sports Water. As part of a growing partnership, PURA has recently acquired a five percent stake in ALKM. In conjunction with that growing partnership, ALKM and PURA plan to pilot the production of multiple new CBD-infused consumer products.
PURA owns a license to a U.S. Patented cannabis extraction process backed by extensive university medical research. The license, issued by NCM Biotech, is exclusive for beverages, edibles and cosmetics among other uses. NCM Biotech is focused on medical research and Puration has access to that research.
PURA and ALKM plan to soon announce beginning production on the new CBD-infused liquid sugar in addition to updates on progress with the additional new products.
For more information on Puration, visit http://www.purationinc.com
For more information, visit www.alkameholdingsinc.com.
CONTACT:
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: [email protected]
Contact:
Puration, Inc.
Brian Shibley,
[email protected]
+1 (800) 861-1350
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/83635
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
StickIt2 weeks ago
StickIt Technologies Inc. Announces Year-End 2023 Financial Results
-
Cannabis2 weeks ago
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis2 weeks ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis2 weeks ago
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis2 weeks ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services
-
Cannabis2 weeks ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller